{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:38:20Z","timestamp":1791308300185,"version":"4.3.1"},"reference-count":98,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T00:00:00Z","timestamp":1659916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Bullous pemphigoid (BP) is the most common autoimmune subepidermal blistering disease. Although the pathomechanism of BP onset has yet to be elucidated in detail, BP autoantibodies targeting two hemidesmosomal components, BP180 and BP230, are known to play a pivotal role in BP pathogenesis. Thus, the detection and measurement of BP autoantibodies are necessary for diagnosing BP and monitoring the disease activity. Immune assays such as immunofluorescence microscopy, immunoblotting, and ELISAs using BP180 and BP230 detect BP autoantibodies in most BP cases with high specificity; however, BP autoantibodies are sometimes detected in BP patients before the onset of this disease. BP autoantibodies that are detected in patients without typical tense blisters are defined as \u201cpreclinical BP autoantibodies\u201d. These preclinical BP autoantibodies are detected even in a low percentage of normal healthy individuals. Although the importance of preclinical BP autoantibodies remains elusive, these autoantibodies might be a potential risk factor for subsequent BP development. Therefore, previous comparative epidemiological studies have focused on the prevalence of preclinical BP autoantibodies in populations susceptible to BP (e.g., the elderly) or in diseases with a higher risk of comorbid BP. This mini-review summarizes the literature on the prevalence of preclinical BP autoantibodies in patients with various conditions and diseases, and we discuss the significance of preclinical BP autoantibody detection.<\/jats:p>","DOI":"10.3389\/fimmu.2022.963401","type":"journal-article","created":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T05:59:02Z","timestamp":1659938342000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["The significance of preclinical anti-BP180 autoantibodies"],"prefix":"10.3389","volume":"13","author":[{"given":"Yosuke","family":"Mai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Izumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoko","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Ujiie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(12)61140-4","article-title":"Pemphigoid diseases","volume":"381","author":"Schmidt","year":"2013","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.clindermatol.2011.03.005","article-title":"Bullous pemphigoid: From the clinic to the bench","volume":"30","author":"Di Zenzo","year":"2012","journal-title":"Clin Dermatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/nm1496","article-title":"Humanization of autoantigen","volume":"13","author":"Nishie","year":"2007","journal-title":"Nat Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1172\/jci116856","article-title":"A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180","volume":"92","author":"Liu","year":"1993","journal-title":"J Clin Invest"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0903101","article-title":"A novel active mouse model for bullous pemphigoid targeting humanized pathogenic antigen","volume":"184","author":"Ujiie","year":"2010","journal-title":"J Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/s0923-1811(02)00109-3","article-title":"BP180 ELISA using bacterial recombinant NC16a protein as a diagnostic and monitoring tool for bullous pemphigoid","volume":"30","author":"Kobayashi","year":"2002","journal-title":"J Dermatol Sci"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/bf02505245","article-title":"The majority of bullous pemphigoid and herpes gestationis serum samples react with the NC16a domain of the 180-kDa bullous pemphigoid antigen","volume":"288","author":"Matsumura","year":"1996","journal-title":"Arch Dermatol Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.15111","article-title":"Japanese Guidelines for the management of pemphigoid (including epidermolysis bullosa acquisita)","volume":"46","author":"Ujiie","year":"2019","journal-title":"J Dermatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.02.003","article-title":"A retrospective review of autoimmune bullous disease antibody positivity prior to clinical symptoms","volume":"86","author":"Raneses","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.07.009","article-title":"Comparative study of direct and indirect immunofluorescence and of bullous pemphigoid 180 and 230 enzyme-linked immunosorbent assays for diagnosis of bullous pemphigoid","volume":"69","author":"S\u00e1rdy","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2017.07.012","article-title":"IgG4, complement, and the mechanisms of blister formation in pemphigus and bullous pemphigoid","volume":"88","author":"Dainichi","year":"2017","journal-title":"J Dermatol Sci"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14411","article-title":"Bullous pemphigoid suggestive of complement-independent blister formation with anti-BP180 IgG4 autoantibodies","volume":"175","author":"Dainichi","year":"2016","journal-title":"Br J Dermatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17044","article-title":"A case of non-bullous pemphigoid induced by IgG4 autoantibodies targeting BP230","volume":"35","author":"Yoshimoto","year":"2021","journal-title":"J Eur Acad Dermatol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-pathol-012615-044313","article-title":"Mechanisms of disease: Pemphigus and bullous pemphigoid","volume":"11","author":"Hammers","year":"2015","journal-title":"Annu Rev Pathol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.136.2.174","article-title":"Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid","volume":"136","author":"Schmidt","year":"2000","journal-title":"Arch Dermatol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0625.2007.00592.x","article-title":"Enzyme-linked immunosorbent assay using multimers of the 16th non-collagenous domain of the BP180 antigen for sensitive and specific detection of pemphigoid autoantibodies","volume":"16","author":"Sitaru","year":"2007","journal-title":"Exp Dermatol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2002.19529.x","article-title":"Severity and phenotype of bullous pemphigoid relate to autoantibody profile against the NH2- and COOH-terminal regions of the BP180 ectodomain","volume":"119","author":"Hofmann","year":"2002","journal-title":"J Invest Dermatol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1046\/j.0022-202x.2003.22126.x","article-title":"Characterization of the anti-BP180 autoantibody reactivity profile and epitope mapping in bullous pemphigoid patients","volume":"122","author":"Di Zenzo","year":"2004","journal-title":"J Invest Dermatol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2004.06245.x","article-title":"Development of a novel ELISA system for detection of anti-BP180 IgG and characterization of autoantibody profile in bullous pemphigoid patients","volume":"151","author":"Mariotti","year":"2004","journal-title":"Br J Dermatol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2008.04.012","article-title":"Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid","volume":"128","author":"Di Zenzo","year":"2008","journal-title":"Clin Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2016.06.622","article-title":"Autoantibody profile differentiates between inflammatory and noninflammatory bullous pemphigoid","volume":"136","author":"Izumi","year":"2016","journal-title":"J Invest Dermatol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-7-49","article-title":"Serological diagnosis of autoimmune bullous skin diseases: Prospective comparison of the BIOCHIP mosaic-based indirect immunofluorescence technique with the conventional multi-step single test strategy","volume":"7","author":"van Beek","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jim.2012.05.007","article-title":"Autoantibody detection in bullous pemphigoid: Clinical evaluation of the EUROPLUSTM dermatology mosaic","volume":"382","author":"Damoiseaux","year":"2012","journal-title":"J Immunol Methods"},{"key":"B24","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1159\/000339776","article-title":"Anti-skin specific autoantibodies detected by a new immunofluorescence multiplex biochip method in patients with autoimmune bullous diseases","volume":"225","author":"Tampoia","year":"2012","journal-title":"Dermatology"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.5402\/2012\/237802","article-title":"Biochip technology for the serological diagnosis of bullous pemphigoid","volume":"2012","author":"Zarian","year":"2012","journal-title":"ISRN Dermatol"},{"key":"B26","article-title":"The value of the BIOCHIP mosaic-based indirect immunofluorescence technique in the diagnosis of pemphigus and bullous pemphigoid in Turkish patients","volume":"25","author":"\u00d6zkesici","year":"2017","journal-title":"Acta Dermatovenerol Croat"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.5114\/ada.2017.65617","article-title":"Accuracy of molecular diagnostics in pemphigus and bullous pemphigoid: Comparison of commercial and modified mosaic indirect immunofluorescence tests as well as enzyme-linked immunosorbent assays","volume":"34","author":"Gornowicz-Porowska","year":"2017","journal-title":"Post\u0229py Dermatol Alergol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.13034","article-title":"A new indirect immunofluorescence BIOCHIP method for the serological diagnosis of bullous pemphigoid: A review of literature","volume":"60","author":"Yang","year":"2019","journal-title":"Australas J Dermatol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/cup.13591","article-title":"The use of BIOCHIP mosaics in diagnostics of bullous pemphigoid: Evaluation and comparison to conventional multistep procedures","volume":"47","author":"Adaszewska","year":"2020","journal-title":"J Cutan Pathol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15770","article-title":"Validation of the BIOCHIP test for the diagnosis of bullous pemphigoid, pemphigus vulgaris and pemphigus foliaceus","volume":"34","author":"Yang","year":"2020","journal-title":"J Eur Acad Dermatol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.13611","article-title":"Comparison of the EUROIMMUN dermatology profile ELISA to the novel BIOCHIP mosaic 7 for the diagnosis of immunobullous skin disease","volume":"62","author":"Simpson","year":"2021","journal-title":"Australas J Dermatol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2011.23","article-title":"Usefulness of BP230 and BP180-NC16a enzyme-linked immunosorbent assays in the initial diagnosis of bullous pemphigoid: A retrospective study of 138 patients","volume":"147","author":"Charneux","year":"2011","journal-title":"Arch Dermatol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2230.2003.01419.x","article-title":"Comparison of immunofluorescence microscopy, immunoblotting and enzyme-linked immunosorbent assay methods in the laboratory diagnosis of bullous pemphigoid","volume":"28","author":"Chan","year":"2003","journal-title":"Clin Exp Dermatol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.02396.x","article-title":"Immunoreactivity of bullous pemphigoid (BP) autoantibodies against the NC16A and c-terminal domains of the 180 kDa BP antigen (BP180): Immunoblot analysis and enzyme-linked immunosorbent assay using BP180 recombinant proteins","volume":"139","author":"Nakatani","year":"1998","journal-title":"Br J Dermatol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2004.06082.x","article-title":"Evaluation of a BP180-NC16a enzyme-linked immunosorbent assay in the initial diagnosis of bullous pemphigoid","volume":"151","author":"Sakuma-Oyama","year":"2004","journal-title":"Br J Dermatol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jdermsci.2005.11.002","article-title":"Enzyme-linked immunosorbent assay using bacterial recombinant proteins of human BP230 as a diagnostic tool for bullous pemphigoid","volume":"41","author":"Yoshida","year":"2006","journal-title":"J Dermatol Sci"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.141.6.705","article-title":"Usefulness of BP180 NC16a enzyme-linked immunosorbent assay in the serodiagnosis of pemphigoid gestationis and in differentiating between pemphigoid gestationis and pruritic urticarial papules and plaques of pregnancy","volume":"141","author":"Powell","year":"2005","journal-title":"Arch Dermatol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-0960.2008.00452.x","article-title":"Autoantibodies to basement membrane proteins BP180 and BP230 are commonly detected in normal subjects by immunoblotting","volume":"49","author":"Desai","year":"2008","journal-title":"Australas J Dermatol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2009.331","article-title":"Anti\u2013bullous pemphigoid 180 and 230 antibodies in a sample of unaffected subjects","volume":"146","author":"Wieland","year":"2010","journal-title":"Arch Dermatol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12739","article-title":"Serum autoantibodies against the dermal\u2013epidermal junction in patients with chronic pruritic disorders, elderly individuals and blood donors prospectively recruited","volume":"170","author":"van Beek","year":"2014","journal-title":"Br J Dermatol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13023-015-0278-x","article-title":"Prevalence of pemphigus and pemphigoid autoantibodies in the general population","volume":"10","author":"Pr\u00fc\u00dfmann","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14538","article-title":"Parkinson Disease and multiple sclerosis are not associated with autoantibodies against structural proteins of the dermal\u2013epidermal junction","volume":"175","author":"Recke","year":"2016","journal-title":"Br J Dermatol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2018.09.010","article-title":"BP180 autoantibodies target different epitopes in multiple sclerosis or alzheimer\u2019s disease than in bullous pemphigoid","volume":"139","author":"Tuusa","year":"2019","journal-title":"J Invest Dermatol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.jid.2021.11.028","article-title":"A 1,035-subject study suggesting a history of bone fracture as a possible factor associated with the development of anti-BP180 autoantibodies","volume":"142","author":"Mai","year":"2021","journal-title":"J Invest Dermatol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1992.01680160075007","article-title":"Frequency of bullous pemphigoid\u2013like antibodies as detected by Western immunoblot analysis in pruritic dermatoses","volume":"128","author":"Rieckhoff-Cantoni","year":"1992","journal-title":"Arch Dermatol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1996.03890340061010","article-title":"Serum from normal elderly individuals contains anti\u2013basement membrane zone antibodies","volume":"132","author":"Hachisuka","year":"1996","journal-title":"Arch Dermatol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2003.05603.x","article-title":"Diagnostic value of an enzyme-linked immunosorbent assay using BP180 recombinant proteins in elderly patients with pruritic skin disorders","volume":"149","author":"Hofmann","year":"2003","journal-title":"Br J Dermatol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09266.x","article-title":"IgG autoantibody reactivity against bullous pemphigoid (BP) 180 and BP230 in elderly patients with pruritic dermatoses","volume":"161","author":"Feliciani","year":"2009","journal-title":"Br J Dermatol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2012.02.003","article-title":"IgE recognition of bullous pemphigoid (BP)180 and BP230 in BP patients and elderly individuals with pruritic dermatoses","volume":"143","author":"Fania","year":"2012","journal-title":"Clin Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2015.12.005","article-title":"Autoantibodies to collagen XVII are present in parkinson\u2019s disease and localize to tyrosine-hydroxylase positive neurons","volume":"136","author":"Messingham","year":"2016","journal-title":"J Invest Dermatol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2016.09.010","article-title":"Increased levels of the bullous pemphigoid BP180 autoantibody are associated with more severe dementia in alzheimer\u2019s disease","volume":"137","author":"Kokkonen","year":"2017","journal-title":"J Invest Dermatol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00236","article-title":"Anti-BP180 autoantibodies are present in stroke and recognize human cutaneous BP180 and BP180-NC16A","volume":"10","author":"Wang","year":"2019","journal-title":"Front Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.21037\/atm-20-5343","article-title":"Analysis of the autoimmune response against BP180 in patients with alzheimer\u2019s disease","volume":"9","author":"Wang","year":"2020","journal-title":"Ann Transl Med"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2008.0483","article-title":"Anti-basement membrane zone antibodies in elderly patients with pruritic disorders and diabetes mellitus","volume":"18","author":"Jedlickova","year":"2008","journal-title":"Eur J Dermatol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01439","article-title":"A cross-sectional study comparing the prevalence of bullous pemphigoid autoantibodies in 275 cases of type II diabetes mellitus treated with or without dipeptidyl peptidase-IV inhibitors","volume":"10","author":"Izumi","year":"2019","journal-title":"Front Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.08.030","article-title":"Prevalence estimates for pemphigoid in the united states: A sex-adjusted and age-adjusted population analysis","volume":"80","author":"Wertenteil","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.a180","article-title":"Bullous pemphigoid and pemphigus vulgaris\u2013incidence and mortality in the UK: population based cohort study","volume":"337","author":"Langan","year":"2008","journal-title":"BMJ"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09300.x","article-title":"Incidence of bullous pemphigoid and pemphigus in Switzerland: A 2-year prospective study","volume":"161","author":"Marazza","year":"2009","journal-title":"Br J Dermatol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1111\/j.1610-0387.2008.06976.x","article-title":"Prospective analysis of the incidence of autoimmune bullous disorders in lower franconia, Germany","volume":"7","author":"Bertram","year":"2009","journal-title":"J Dtsch Dermatol Ges"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2013.756","article-title":"Bullous pemphigoid as pruritus in the elderly: A common presentation","volume":"149","author":"Bakker","year":"2013","journal-title":"JAMA Dermatol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.282023","article-title":"Pruritus in the older patient: A clinical review","volume":"310","author":"Berger","year":"2013","journal-title":"JAMA"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2004.02457.x","article-title":"Prodromal bullous pemphigoid","volume":"45","author":"Lamb","year":"2006","journal-title":"Int J Dermatol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.jaad.2017.10.035","article-title":"Nonbullous pemphigoid: A systematic review","volume":"78","author":"Lamberts","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2015.01.006","article-title":"Atypical presentations of bullous pemphigoid: Clinical and immunopathological aspects","volume":"14","author":"Cozzani","year":"2015","journal-title":"Autoimmun Rev"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(92)70264-g","article-title":"Dermatomyositis pemphigoides: A case with coexistent dermatomyositis and bullous pemphigoid","volume":"27","author":"Glover","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2007.02368.x","article-title":"Bullous pemphigoid associated with dermatomyositis and colon carcinoma","volume":"32","author":"Yanagi","year":"2007","journal-title":"Clin Exp Dermatol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1997.tb03301.x","article-title":"Bullous pemphigoid associated with systemic lupus erythematosus: the discrimination of antibasement membrane zone antibody","volume":"36","author":"Huang","year":"1997","journal-title":"Int J Dermatol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.02534.x","article-title":"Bullous pemphigoid associated with systemic lupus erythematosus","volume":"139","author":"Loche","year":"1998","journal-title":"Br J Dermatol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.4646-20","article-title":"Drug-induced bullous pemphigoid and lupus erythematosus occurring under anti-TNF-\u03b1 and IL-6 therapy in a patient with rheumatoid arthritis","volume":"59","author":"Yoshikawa","year":"2020","journal-title":"Internal Med"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/s0190-9622(81)80202-2","article-title":"Bullous pemphigoid and rheumatoid arthritis","volume":"4","author":"Giannini","year":"1981","journal-title":"J Am Acad Dermatol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1007\/bf02944199","article-title":"Bullous pemphigoid and rheumatoid arthritis: Is there disease association","volume":"166","author":"Sant","year":"1997","journal-title":"Ir J Med Sci"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2017.3012","article-title":"Bullous pemphigoid and systemic sclerosis: An incidental association","volume":"27","author":"Cozzani","year":"2017","journal-title":"Eur J Dermatol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/0738-081x(87)90051-4","article-title":"Bullous pemphigoid: Associated diseases","volume":"5","author":"Dahl","year":"1987","journal-title":"Clin Dermatol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12136","article-title":"Immunopathological characteristics of patients with bullous pemphigoid and neurological disease","volume":"28","author":"Taghipour","year":"2014","journal-title":"J Eur Acad Dermatol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2010.357","article-title":"The relationship between neurological disease and bullous pemphigoid: A population-based case\u2013control study","volume":"131","author":"Langan","year":"2011","journal-title":"J Invest Dermatol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"096","DOI":"10.1684\/ejd.2010.0805","article-title":"Bullous pemphigoid and internal diseases \u2013 a case-control study","volume":"20","author":"Jedlickova","year":"2010","journal-title":"Eur J Dermatol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13660","article-title":"Bullous pemphigoid and its association with neurological diseases: A systematic review and meta-analysis","volume":"30","author":"Lai","year":"2016","journal-title":"J Eur Acad Dermatol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1038\/srep37125","article-title":"Psychiatric and neurological disorders are associated with bullous pemphigoid \u2013 a nationwide Finnish care register study","volume":"6","author":"F\u00f6rsti","year":"2016","journal-title":"Sci Rep"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12664","article-title":"High prevalence of cutaneous manifestations in the elderly with diabetes mellitus: An institution-based cross-sectional study in Taiwan","volume":"29","author":"Tseng","year":"2015","journal-title":"J Eur Acad Dermatol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1001\/jamadermatol.2020.1587","article-title":"Association between medication use and bullous pemphigoid","volume":"156","author":"Liu","year":"2020","journal-title":"JAMA Dermatol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2011.04062.x","article-title":"Drug-induced bullous pemphigoid in diabetes mellitus patients receiving dipeptidyl peptidase-IV inhibitors plus metformin","volume":"26","author":"Skandalis","year":"2012","journal-title":"J Eur Acad Dermatol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/bjd.14601","article-title":"Centres the FA of RP. bullous pemphigoid and dipeptidyl peptidase IV inhibitors: A case\u2013noncase study in the French pharmacovigilance database","volume":"175","author":"B\u00e9n\u00e9","year":"2016","journal-title":"Br J Dermatol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2018.4556","article-title":"Association of dipeptidyl peptidase 4 inhibitor use with risk of bullous pemphigoid in patients with diabetes","volume":"155","author":"Lee","year":"2019","journal-title":"JAMA Dermatol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1001\/jamadermatol.2018.2352","article-title":"Association of bullous pemphigoid with dipeptidyl-peptidase 4 inhibitors in patients with diabetes: Estimating the risk of the new agents and characterizing the patients","volume":"154","author":"Kridin","year":"2018","journal-title":"JAMA Dermatol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.12.038","article-title":"Dipeptidyl peptidase IV inhibitors, a risk factor for bullous pemphigoid: Retrospective multicenter case-control study from France and Switzerland","volume":"78","author":"Benzaquen","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2018.01.027","article-title":"Vildagliptin significantly increases the risk of bullous pemphigoid: A Finnish nationwide registry study","volume":"138","author":"Varpuluoma","year":"2018","journal-title":"J Invest Dermatol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2012.11108.x","article-title":"Clinical presentation and diagnostic delay in bullous pemphigoid: A prospective nationwide cohort","volume":"167","author":"della Torre","year":"2012","journal-title":"Br J Dermatol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1988.tb02405.x","article-title":"The prodrome of bullous pemphigoid","volume":"27","author":"Amato","year":"1988","journal-title":"Int J Dermatol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2008.00498.x","article-title":"Bullous pemphigoid with a prolonged prodrome","volume":"35","author":"Nakatani","year":"2008","journal-title":"J Dermatol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.13782","article-title":"Non-bullous lesions as the first manifestation of bullous pemphigoid: A retrospective analysis of 181 cases","volume":"44","author":"Zhang","year":"2017","journal-title":"J Dermatol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1080\/09546630802683876","article-title":"Non-bullous lesions as the first manifestation of bullous pemphigoid: A retrospective analysis of 24 cases","volume":"20","author":"Sun","year":"2009","journal-title":"J Dermatol Treat"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.04.029","article-title":"Nonbullous pemphigoid: Insights in clinical and diagnostic findings, treatment responses, and prognosis","volume":"81","author":"Lamberts","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2018.4390","article-title":"Assessment of diagnostic strategy for early recognition of bullous and nonbullous variants of pemphigoid","volume":"155","author":"Meijer","year":"2019","journal-title":"JAMA Dermatol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(93)70179-w","article-title":"Nonbullous pemphigoid: Prodrome of bullous pemphigoid or a distinct pemphigoid variant","volume":"29","author":"Strohal","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.01.017","article-title":"Immunoglobulin M pemphigoid","volume":"85","author":"Boch","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.16260","article-title":"Super-resolution imaging detects BP180 autoantigen in immunoglobulin m pemphigoid","volume":"49","author":"Hirano","year":"2022","journal-title":"J Dermatol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2020.04.008","article-title":"Immunoglobulin m bullous pemphigoid: An enigma","volume":"6","author":"Baardman","year":"2020","journal-title":"JAAD Case Rep"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.03.062","article-title":"Circulating bullous pemphigoid autoantibodies in the setting of negative direct immunofluorescence findings for bullous pemphigoid: A single-center retrospective review","volume":"81","author":"Wang","year":"2019","journal-title":"J Am Acad Dermatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.963401\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T05:59:05Z","timestamp":1659938345000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.963401\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,8]]},"references-count":98,"alternative-id":["10.3389\/fimmu.2022.963401"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.963401","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,8]]},"article-number":"963401"}}